111 related articles for article (PubMed ID: 5430391)
1. Ortho 1557-O. A new oral contraceptive.
Ledger WJ
Int J Fertil; 1970; 15(2):88-92. PubMed ID: 5430391
[No Abstract] [Full Text] [Related]
2. [Amenorrhea, anovulation and oligomenorrhea due to use of oral contraceptives].
James M; Rozenbaum H
Concours Med; 1974 Mar; 96(10):1559-60, 1563-4, 1567-8. PubMed ID: 4619979
[No Abstract] [Full Text] [Related]
3. The oversuppression syndrome.
Horowitz BJ; Solomkin M; Edelstein SW
Obstet Gynecol; 1968 Mar; 31(3):387-9. PubMed ID: 5639193
[No Abstract] [Full Text] [Related]
4. Strokes in young women using oral contraceptives.
Cole M
Arch Intern Med; 1967 Nov; 120(5):551-5. PubMed ID: 6054589
[No Abstract] [Full Text] [Related]
5. [Menstruation disorders due to Ovosiston medication].
Kühndel K; Ebeling K; Rothe K
Dtsch Gesundheitsw; 1971 Jan; 26(3):109-13. PubMed ID: 4106361
[No Abstract] [Full Text] [Related]
6. [Contraception with Monogest in young women].
Chalupa M
Cesk Gynekol; 1981 May; 46(4):300-1. PubMed ID: 7249099
[TBL] [Abstract][Full Text] [Related]
7. Mood and behavioural changes with progestational agents.
Kane FJ; Daly RJ; Ewing JA; Keeler MH
Br J Psychiatry; 1967 Mar; 113(496):265-8. PubMed ID: 6029624
[No Abstract] [Full Text] [Related]
8. [Biochemical and steroidal indicators in the use of Monogest, a progesterone contraceptive].
Kobilková J; Zizkovská E; Trnka V
Cesk Gynekol; 1981 Aug; 46(7):540-1. PubMed ID: 7285177
[No Abstract] [Full Text] [Related]
9. [Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic].
de Sampaio Júnior LF; Dib JE; Pereira VM; Neme B
Matern Infanc (Sao Paulo); 1971; 30(1):65-9. PubMed ID: 5135370
[No Abstract] [Full Text] [Related]
10. Galactorrhea after contraceptive hormones.
Gregg WI
N Engl J Med; 1966 Jun; 274(25):1432. PubMed ID: 5949006
[No Abstract] [Full Text] [Related]
11. Some apparently common problems in patients receiving contraceptive pills.
Ball P
Nebr State Med J; 1968 Sep; 53(9):428-32. PubMed ID: 4176717
[No Abstract] [Full Text] [Related]
12. [Clinical use of combined tablets of norethisterone 1.0 mg and mestranol.05 mg].
Domon H; Washizuka N; Ishikawa M
Horumon To Rinsho; 1969 Feb; 17(2):133-6. PubMed ID: 5815262
[No Abstract] [Full Text] [Related]
13. A new oral contraceptive with a 7 plus 15 sequential formulation.
Brosens I; Van Assche A; Wijnants P
Arzneimittelforschung; 1970 Feb; 20(2):236-7. PubMed ID: 5467468
[No Abstract] [Full Text] [Related]
14. Clinical evaluation of a new sequential oral contraceptive agent.
Cowan LE
Can Med Assoc J; 1967 Apr; 96(17):1208-11. PubMed ID: 6022790
[TBL] [Abstract][Full Text] [Related]
15. [Use of an estroprogestinic association (norethindrone 2 mg and mestranol 100 gamma) in dysfunctional gynecologic syndromes].
Capra A; Trompeo P; Garetto A; Campagnoli C
Minerva Ginecol; 1969 Aug; 21(15):967-86. PubMed ID: 5404341
[No Abstract] [Full Text] [Related]
16. Erythema nodosum from oral contraceptives.
Baden HP; Holcomb FD
Arch Dermatol; 1968 Dec; 98(6):634-5. PubMed ID: 5697233
[No Abstract] [Full Text] [Related]
17. [Menstruation and endometrium after hormonal contraception].
Böhm W; Klinger G; Hempel E
Zentralbl Gynakol; 1972 Jul; 94(30):945-51. PubMed ID: 4118151
[No Abstract] [Full Text] [Related]
18. Secondary hyperparathyroidism caused by oral contraceptives.
Moses AM; Notman DD
Arch Intern Med; 1982 Jan; 142(1):128-9. PubMed ID: 6274264
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of a sequential oral contraceptive tablet.
Newland DO; Mintzer AJ; Kennedy RF; Kendall T
Obstet Gynecol; 1966 Oct; 28(4):516-20. PubMed ID: 5925039
[No Abstract] [Full Text] [Related]
20. The oral contraceptive norinyl-1 in porphyria.
Goldswain PR; Eales L
S Afr Med J; 1971 Sep; ():111-9. PubMed ID: 5150263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
